Seed · Biotech · Leuven, Belgium · 9–20 employees
Montis Biosciences is a Leuven-based preclinical biopharmaceutical company developing next-generation immuno-modulating therapeutics that target complement C1q and the myeloid axis to treat inflammation-driven neurodegenerative diseases, autoimmune disorders and certain cancers; working here offers biotech researchers and translational scientists the chance to contribute to cutting-edge therapeutic discovery from foundational science in partnership with VIB and KU Leuven, shape early pipelines with world-class advisors, and help push first-in-class programs toward clinical trials.
No open roles listed right now.